Clinical value of combined detection of multiple serum tumor markers in the diagnosis of NSCLC

Xing-bing LU,LI-Qin,SHI-Jia,LIU-Bo,Shu-yu YANG,CHE-Juan,Su-gen ZENG,Yi XIE
DOI: https://doi.org/10.3969/j.issn.1671-7562.2017.10.007
2017-01-01
Abstract:Objective:To evaluate the clinical value of NSE,CYfra21-1,CA199,CEA and serum lactate dehydrogenase (LDH) in the auxiliary diagnosis of NSCLC.Methods:The levels of of the five tumor markers were detected in 283 cases of NSCLC by using electrochemical luminescence and enzymatic methods,of whom 192 cases were of benign lung disease and 207 individuals of healthy physical examination.Results:The levels of the serum tumor markers from NSCLC group were significantly higher than those from lung benign cases and individuals of healthy physical examination (P < 0.05).The expression levels of CEA in adenocarcinoma were significantly higher than those of squamous cell carcinoma,and the content of Cyfra21-1 in squamous cell carcinoma was higher than that of adenocarcinoma(P <0.05).The levels of NSE,Cyfra21-1,CEA and LDH of NSCLC group in stage T1/T2 were lower than those in T3/T4,and the levels of NSE,Cyfra21-1,CA199,CEA and LDH of NSCLC group in the Ⅲ/Ⅳ stage were higher than those in the Ⅰ / Ⅱ stage.The sensitivity and accuracy of combined detection were significantly higher than those of single assay.Cyfra21-1 and CEA had the highest diagnostic efficacy for NSCLC,CEA had the highest diagnostic efficacy for adenocarcinoma and Cyfra21-1 had the highest diagnostic efficacy for squamous cell carcinoma of the lung.Conclusion:The five kinds of serum tumor markers are highly expressed in patients with NSCLC and significantly associated with the clinical stage and TNM classification of NSCLC.Combined detection of them can significantly improve the sensitivity and specificity of diagnosis,and has important reference value for the early diagnosis,treatment monitoring and prognosis judgment of NSCLC.
What problem does this paper attempt to address?